Novo Nordisk A/S (NVO) News Today → WARNING about the death of the U.S. dollar… (From Colonial Metals) (Ad) Free NVO Stock Alerts $134.08 -1.96 (-1.44%) (As of 05/28/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 28 at 5:33 PM | msn.comNovo Nordisk Faces Scrutiny Over High Prices of Ozempic And Wegovy, Blames US Health SystemMay 28 at 5:33 PM | finance.yahoo.comSector Update: Health Care Stocks Fall Late AfternoonMay 28 at 3:38 PM | marketbeat.comNovo Nordisk A/S (NYSE:NVO) Shares Bought by Steward Partners Investment Advisory LLCSteward Partners Investment Advisory LLC lifted its stake in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) by 13.8% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 155,397 shares of the company's stock after purcMay 28 at 12:32 PM | msn.comOzempic Maker Novo Nordisk's Increasing Influence On Denmark's Employment Raises Economic ConcernsMay 28 at 12:32 PM | finance.yahoo.comMarket Chatter: Novo Nordisk Tells US Senate Health Committee Chair Sanders It Only Keeps 60% of Ozempic, Wegovy List PriceMay 28 at 8:41 AM | marketbeat.comLifeMD Can Surge on Its GLP-1 Offerings (NVO)LifeMD is a leading telehealth provider that investors should take note of; the company is entering the GLP-1 market, and its stock could soar as a resultMay 28 at 7:59 AM | reuters.comNovo blames US health system after criticism over Wegovy price, Bloomberg reportsMay 28 at 7:32 AM | finance.yahoo.comAnalysis-Weight-loss drug forecasts jump to $150 billion as supply growsMay 28 at 1:18 AM | marketbeat.comNovo Nordisk A/S (NYSE:NVO) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesNovo Nordisk A/S (NYSE:NVO - Get Free Report) has received an average recommendation of "Moderate Buy" from the eight ratings firms that are presently covering the company, Marketbeat.com reports. Two research analysts have rated the stock with a hold rating and six have issued a buy rating on thMay 27 at 3:45 PM | markets.businessinsider.comBuy Rating Affirmed for Novo Nordisk on Strong Clinical Data and Competitive Edge in Metabolic Disease TreatmentMay 27 at 12:32 PM | investorplace.com7 Biotech Stocks to Put on Your Breakthrough RadarMay 27 at 8:49 AM | globenewswire.comNovo Nordisk A/S - share repurchase programmeMay 25 at 8:22 PM | marketbeat.comAdvisory Services Network LLC Boosts Stock Holdings in Novo Nordisk A/S (NYSE:NVO)Advisory Services Network LLC grew its position in Novo Nordisk A/S (NYSE:NVO - Free Report) by 50.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 55,552 shares of the company's stock after purchasinMay 25 at 11:04 AM | markets.businessinsider.comStudy Says Novo Nordisk's Ozempic Reduces Kidney Disease RisksMay 25 at 11:04 AM | msn.comNovo Nordisk’s Wegovy improves kidney health in addition to weight loss: studyMay 25 at 9:15 AM | fool.comWhere Will Novo Nordisk Be in 10 Years?May 25 at 7:27 AM | reuters.comWegovy users have less kidney-related health problems, analysis of Novo study findsMay 25 at 6:47 AM | fool.com3 High-Flying Stocks That Could Soar Even MoreMay 24, 2024 | marketbeat.comOrion Portfolio Solutions LLC Has $32.99 Million Position in Novo Nordisk A/S (NYSE:NVO)Orion Portfolio Solutions LLC lifted its stake in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) by 44.3% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 310,087 shares of the company's stock after purchasing an additiMay 24, 2024 | reuters.comUS FDA panel votes against use of Novo Nordisk's weekly insulin in type 1 diabetes patientsMay 24, 2024 | msn.comNovo Nordisk Releases Data Showing Ozempic For Diabetes Slows Kidney Disease ProgressionMay 24, 2024 | reuters.comNovo Nordisk's Ozempic slows diabetic kidney disease progression in trialMay 23, 2024 | marketbeat.comCypress Asset Management Inc. TX Buys New Position in Novo Nordisk A/S (NYSE:NVO)Cypress Asset Management Inc. TX purchased a new position in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 17,695 shares of the company's stock, valued atMay 23, 2024 | bloomberg.comNovo Nordisk Fire Extinguished at Danish Headquarters ComplexMay 22, 2024 | finance.yahoo.comNovo Nordisk's Once-Weekly Insulin Flagged With Risk Of Low Blood Sugar Ahead Of FDA ReviewMay 22, 2024 | marketbeat.comAigen Investment Management LP Purchases Shares of 7,161 Novo Nordisk A/S (NYSE:NVO)Aigen Investment Management LP purchased a new stake in Novo Nordisk A/S (NYSE:NVO - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 7,161 shares of the company's stock, valued at approximately $741,000. A number oMay 22, 2024 | reuters.comUS FDA staff flags risk of low blood sugar for Novo Nordisk's weekly insulinMay 21, 2024 | msn.com58% of Novo Nordisk’s (NYSE:NVO) Saxenda and Wegovy Users Quit EarlyMay 21, 2024 | cnbc.comHealthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulinsMay 21, 2024 | marketbeat.comCorient Private Wealth LLC Has $129.13 Million Stake in Novo Nordisk A/S (NYSE:NVO)Corient Private Wealth LLC grew its holdings in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) by 49.3% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,248,215 shares of the company's stock aMay 21, 2024 | marketbeat.comThoroughbred Financial Services LLC Boosts Stock Position in Novo Nordisk A/S (NYSE:NVO)Thoroughbred Financial Services LLC raised its stake in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) by 77.6% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 34,704 shares of the company's stock after acquirMay 20, 2024 | finance.yahoo.comHims & Hers Health to Offer GLP-1 Weight Loss Injections; Stock SoarsMay 20, 2024 | marketbeat.comTrexquant Investment LP Makes New $27 Million Investment in Novo Nordisk A/S (NYSE:NVO)Trexquant Investment LP bought a new stake in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 261,019 shares of the company's stock, valued at approximately $27,002,000. NMay 20, 2024 | marketbeat.comNovo Nordisk A/S (NYSE:NVO) Trading 0.6% Higher Novo Nordisk A/S (NYSE:NVO) Trading 0.6% HigherMay 20, 2024 | investorplace.com7 Biotech Stocks That Could Breathe New Life Into Your PortfolioMay 20, 2024 | finance.yahoo.comGenetic Profile Key To Novo Nordisk's Wegovy's Weight-Loss Effectiveness, Study RevealsMay 19, 2024 | marketbeat.comGlaxis Capital Management LLC Makes New $1.03 Million Investment in Novo Nordisk A/S (NYSE:NVO)Glaxis Capital Management LLC bought a new position in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 10,000 shares of the company's stock, valueMay 18, 2024 | marketbeat.comNovo Nordisk A/S (NYSE:NVO) Position Trimmed by Dillon & Associates Inc.Dillon & Associates Inc. lessened its holdings in Novo Nordisk A/S (NYSE:NVO - Free Report) by 3.0% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 274,008 shares of the company's stock after selling 8,469 shares during the quarter. NovMay 18, 2024 | fool.comIs Novo Nordisk Stock a Millionaire Maker?May 17, 2024 | marketbeat.comM. Kulyk & Associates LLC Buys New Shares in Novo Nordisk A/S (NYSE:NVO)M. Kulyk & Associates LLC bought a new stake in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) in the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 5,860 shares of the company's stock, valued at approximately $606,000. Several other large invMay 17, 2024 | investorplace.comPharma Stocks Outlook: Where Are 2024's Top Performers Headed Next?May 17, 2024 | globenewswire.comNovo Nordisk A/S - share repurchase programmeMay 16, 2024 | reuters.comNovo Nordisk building site hit by fire, Danish TV2 reportsMay 16, 2024 | finance.yahoo.comFire at Novo Nordisk Construction Site Gives Investors A ScareMay 16, 2024 | uk.finance.yahoo.comOzempic drives economic boom in Denmark as growth forecasts doubledMay 16, 2024 | uk.investing.comNovo Nordisk remains the most well-held European stock: Morgan StanleyMay 16, 2024 | yahoo.comDenmark Raises Growth Forecast as Novo Nordisk Expands OutputMay 16, 2024 | investorplace.com7 Pharma Stocks Harnessing AI Brainpower for Big BreakthroughsMay 16, 2024 | investorplace.comPatent Peril: 3 Stocks at Risk From the FTC's Drug CrusadeMay 15, 2024 | marketbeat.comJanney Montgomery Scott LLC Buys 15,392 Shares of Novo Nordisk A/S (NYSE:NVO)Janney Montgomery Scott LLC lifted its stake in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) by 5.3% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 305,178 shares of the company's stock after acquiring an additional Get Novo Nordisk A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for NVO and its competitors with MarketBeat's FREE daily newsletter. Email Address Wall Street Legend Warns: "A Strange Day Is Coming to America" (Ad)Get Your Cash Out of U.S. Banks Immediately Man who predicted 2023 bank run warns a historic financial reset is coming. Get out of cash and into a new vehicle 50 years in the making. Click here to learn more. NVO Media Mentions By Week NVO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVO News Sentiment▼0.500.89▲Average Medical News Sentiment NVO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVO Articles This Week▼2724▲NVO Articles Average Week Get Novo Nordisk A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for NVO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Eli Lilly and Company News Today Johnson & Johnson News Today Merck & Co., Inc. News Today AbbVie News Today AstraZeneca News Today Novartis News Today Abbott Laboratories News Today Pfizer News Today Sanofi News Today Vertex Pharmaceuticals News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:NVO) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersBiggest Prediction of My 50-Year Career on Wall StreetChaikin AnalyticsBitcoin’s Biggest Year YetParadigm PressThe #1 Crypto for AIWeiss RatingsDigitizing the $11T commodities sector with one tiny stockResource Stock DigestTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy SykesElon’s New Device is About to Shock the WorldInvestorPlaceHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novo Nordisk A/S Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
